(Q45245194)

11 December 2017

Cost-effectiveness of venlafaxine XL compared with diazepam in the treatment of generalised anxiety disorder in the United Kingdom (English)

1 reference

11 December 2017

0 references

1 reference

J F Guest

1

1 reference

11 December 2017

J Russ

series ordinal

2

1 reference

11 December 2017

A Lenox-Smith

series ordinal

3

1 reference

11 December 2017

1 June 2005

1 reference

The European Journal of Health Economics

11 December 2017

1 reference

11 December 2017

6

1 reference

11 December 2017

136-145

1 reference

11 December 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s10198-004-0272-z

11 December 2017

0 references

cites work

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

1 reference

https://api.crossref.org/works/10.1007%2FS10198-004-0272-Z

Crossref

reference URL

DSM-III-R generalized anxiety disorder in the National Comorbidity Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-004-0272-Z

Crossref

reference URL

Health care costs associated with depressive and anxiety disorders in primary care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-004-0272-Z

Crossref

reference URL

10.1007/S10198-004-0272-Z

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

11 December 2017

0 references

1 reference